Literature DB >> 1185800

Problems associated with study of cell-mediated immunity to human tumors by microcytotoxicity assays.

R B Herberman, R K Oldham.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1185800     DOI: 10.1093/jnci/55.4.749

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  17 in total

1.  Immunological tests in carcinoma of the prostate.

Authors:  C M Evans; J G Bowen
Journal:  Proc R Soc Med       Date:  1977-06

2.  The biology of human brain tumours.

Authors:  P Kumar
Journal:  Acta Neurochir (Wien)       Date:  1979       Impact factor: 2.216

Review 3.  Immunology of bronchial carcinoma.

Authors:  D A Evans
Journal:  Thorax       Date:  1976-10       Impact factor: 9.139

Review 4.  Natural killer cells: artifact to reality: an odyssey in biology.

Authors:  R K Oldham
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

5.  Logistics of tumor immunology.

Authors:  H Kirchner
Journal:  Klin Wochenschr       Date:  1982-01-04

6.  The in vitro discrimination of rat immune and natural cytotoxicity by serum choice.

Authors:  V J Lindsay; R A Allardyce
Journal:  Immunology       Date:  1980-08       Impact factor: 7.397

7.  Natural killer cell activities of patients with breast cancer against different target cells.

Authors:  G Hamilton; A Reiner; B Teleky; E Roth; R Kolb; J Spona; R Jakesz
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

8.  Studies on the mechanism of rat natural cellular cytotoxicity and its inhibition by normal rat serum.

Authors:  V J Lindsay; R A Allardyce
Journal:  Immunology       Date:  1981-05       Impact factor: 7.397

9.  Cellular cytotoxicity in transitional cell carcinoma of the human urinary bladder - a summary.

Authors:  P Perlmann; M Troye; G Pape; H Blomgren; B Johansson
Journal:  Urol Res       Date:  1978

10.  Cytotoxic effector cells from infectious mononucleosis patients in the acute phase do not specifically kill Epstein-Barr virus genome-carrying lymphoid cell lines.

Authors:  P C Patel; G Dorval; J Menezes
Journal:  Infect Immun       Date:  1982-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.